Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: National Cancer Institute Director's Consumer Liaison Group.
Date: June 30, 2008.
Time: 1 p.m. to 3 p.m.
Agenda: (1) Approval of Minutes; (2) Reports from Dr. John E. Niederhuber, NCI Director; (3) Report from Shannon Bell, OAR Director; (4) Update on issue of the CIRB; (5) Update on the Advocates in Research Working Group; (6) Report of Recommendations Working Group; (7) Reports from DCLG members on NCI Committee Assignments; (8) Public Comment; (9) Action Items and Conclusion.
Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Barbara Guest, Executive Secretary, Office of Advocacy Relations, National Cancer Institute, National Institutes of Health, 31 Center Drive, Bldg. 31, Room 10A30D, Bethesda, MD 20892, 301-496-0307, firstname.lastname@example.org.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)Start Signature
Dated: May 14, 2008.
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-11444 Filed 5-21-08; 8:45 am]
BILLING CODE 4140-01-P